Advertisement
Research Article

Outcomes after Chemotherapy with WHO Category II Regimen in a Population with High Prevalence of Drug Resistant Tuberculosis

  • Francine Matthys mail,

    fmatthys@itg.be

    Affiliation: Epidemiological and Disease Control Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium

    X
  • Leen Rigouts,

    Affiliation: Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium

    X
  • Vinciane Sizaire,

    Affiliation: Médecins sans Frontières, Brussels, Belgium

    X
  • Natalia Vezhnina,

    Affiliation: HIV/TB Penal System Projects in Central Asian Republics, AIDS Foundation East-West, Alma Ata, Kazakhstan

    X
  • Maryvonne Lecoq,

    Affiliation: Médecins sans Frontières, Brussels, Belgium

    X
  • Vera Golubeva,

    Affiliation: Laboratory of Mycobacteriology, Colony 33, Mariinsk, Kemorovo, Russia

    X
  • Françoise Portaels,

    Affiliation: Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium

    X
  • Patrick Van der Stuyft,

    Affiliation: Epidemiological and Disease Control Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium

    X
  • Michael Kimerling

    Affiliation: University of Alabama at Birmingham, Birmingham, Alabama, United States of America

    Current address: The Bill and Melinda Gates Foundation, Seattle, Washington, United States of America

    X
  • Published: November 23, 2009
  • DOI: 10.1371/journal.pone.0007954

Reader Comments (0)

Post a new comment on this article